Evidence map›Paper›PMID 34065854›Full record

ArticleMolecules (Basel, Switzerland)2021

An Integrated Approach toward NanoBRET Tracers for Analysis of GPCR Ligand Engagement.

Michael P Killoran, Sergiy Levin, Michelle E Boursier, Kristopher Zimmerman, Robin Hurst, Mary P Hall, Thomas Machleidt, Thomas A Kirkland, Rachel Friedman Ohana

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Molecular pharmacology · 2024
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Michael P KilloranPromega Corporation, 2800 Woods Hollow, Fitchburg, WI 53711, USA.ORCID 0000-0002-0529-7590
Sergiy LevinPromega Biosciences LLC, 277 Granada Drive, San Luis Obispo, CA 93401, USA.
Michelle E BoursierPromega Corporation, 2800 Woods Hollow, Fitchburg, WI 53711, USA.ORCID 0000-0002-2642-1802
Kristopher ZimmermanPromega Corporation, 2800 Woods Hollow, Fitchburg, WI 53711, USA.
Robin HurstPromega Corporation, 2800 Woods Hollow, Fitchburg, WI 53711, USA.
Mary P HallPromega Corporation, 2800 Woods Hollow, Fitchburg, WI 53711, USA.
Thomas MachleidtPromega Corporation, 2800 Woods Hollow, Fitchburg, WI 53711, USA.
Thomas A KirklandPromega Biosciences LLC, 277 Granada Drive, San Luis Obispo, CA 93401, USA.ORCID 0000-0003-0859-5785
Rachel Friedman OhanaPromega Corporation, 2800 Woods Hollow, Fitchburg, WI 53711, USA.ORCID 0000-0001-6706-4592
Promega (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gaining insight into the pharmacology of ligand engagement with G-protein coupled receptors (GPCRs) under biologically relevant conditions is vital to both drug discovery and basic research. NanoLuc-based bioluminescence resonance energy transfer (NanoBRET) monitoring competitive binding between fluorescent tracers and unmodified test compounds has emerged as a robust and sensitive method to quantify ligand engagement with specific GPCRs genetically fused to NanoLuc luciferase or the luminogenic HiBiT peptide. However, development of fluorescent tracers is often challenging and remains the principal bottleneck for this approach. One way to alleviate the burden of developing a specific tracer for each receptor is using promiscuous tracers, which is made possible by the intrinsic specificity of BRET. Here, we devised an integrated tracer discovery workflow that couples machine learning-guided in silico screening for scaffolds displaying promiscuous binding to GPCRs with a blend of synthetic strategies to rapidly generate multiple tracer candidates. Subsequently, these candidates were evaluated for binding in a NanoBRET ligand-engagement screen across a library of HiBiT-tagged GPCRs. Employing this workflow, we generated several promiscuous fluorescent tracers that can effectively engage multiple GPCRs, demonstrating the efficiency of this approach. We believe that this workflow has the potential to accelerate discovery of NanoBRET fluorescent tracers for GPCRs and other target classes.

Indexed as

Binding, CompetitiveMachine LearningBioluminescence Resonance Energy Transfer TechniquesDrug DiscoveryHEK293 CellsHumansLigandsLuciferasesLuminescent AgentsMolecular Docking SimulationProtein BindingReceptors, G-Protein-CoupledTransfectionLigandsLuciferasesLuminescent AgentsReceptors, G-Protein-CoupledGPCRSHiBiTin silico screenligand-engagementNanoBRET

Identifiers

PMID34065854
PMCPMC8151276
OpenAlexW3160759420

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.